A detailed history of Campbell & CO Investment Adviser LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 6,476 shares of ASND stock, worth $830,223. This represents 0.07% of its overall portfolio holdings.

Number of Shares
6,476
Previous 17,260 62.48%
Holding current value
$830,223
Previous $2.35 Million 58.9%
% of portfolio
0.07%
Previous 0.2%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$113.0 - $153.43 $1.22 Million - $1.65 Million
-10,784 Reduced 62.48%
6,476 $967,000
Q2 2024

Aug 13, 2024

BUY
$121.07 - $153.67 $2.09 Million - $2.65 Million
17,260 New
17,260 $2.35 Million
Q4 2023

Feb 13, 2024

BUY
$86.1 - $127.36 $344,141 - $509,057
3,997 New
3,997 $503,000
Q4 2021

Feb 10, 2022

SELL
$127.1 - $169.66 $368,590 - $492,014
-2,900 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$112.67 - $176.92 $326,743 - $513,067
2,900 New
2,900 $462,000

Others Institutions Holding ASND

About Ascendis Pharma A/S


  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $7.15B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.